Search  in | Advanced
   Print  
NBF Grant Recipients’ Lecture and Luncheon


DATE: Saturday, October 24, 2009

 

TIME: 12:00 p.m.-2:00 p.m.

 

DIRECTOR/MODERATOR: Connie Westhoff, SBB, PhD

 

SPEAKERS:

 

Lan Zhou, MD, PhD, Assistant Professor, Medical Director of Molecular Diagnostic Lab, Case Western Reserve University, Regulation of Granulopoiesis by Fucosylated Glycans through Selectin-Mediated Adhesion and Fringe-Modified Notch Signaling Pathways, 2009 Pall Prize Winner

 

Taku Kambayashi, MD, PhD, Assistant Professor, University of Pennsylvania-Department of Pathology and Laboratory Medicine, The Role of GMCSF in Regulatory T Cell Proleration and Homeostasis, 2009 NBF Grantee

 

Jeanne E. Hendrickson, MD, Department of Pathology, Emory University School of Medicine, Department of Transfusion Medicine, Children’s Hospital, Effect of Host Inflammation on Alloimmunization to RBC Transfusion, 2006 NBF Grantee

 

 

INTENDED AUDIENCE: Physicians, Scientists, Technologists

 

EVENT LEVEL: Intermediate to Advanced

 

EVENT DESCRIPTION: This annual event, offering CME credit, includes presentations from National Blood Foundation (NBF) scientific research grant recipients.  The purpose of this event is to present cutting-edge research that is highly relevant to transfusion medicine, that has the potential to advance the field, and that is currently in progress and not available elsewhere.  Presentations are in a structured format, including background, materials, and methods, data and discussion of significance. The competition to be a grant recipient and presenter is overseen by the NBF Grant Review Committee.  Registration is limited to the first 100 who register for this event with their AABB Annual Meeting full registration.

 

OBJECTIVES: 

·         To discuss the current areas of cutting-edge research in transfusion medicine

·         To describe the methods that can be used to investigate outstanding questions in transfusion medicine

·         To explain the important role of NBF in funding early stage high-impact research with the potential to advance transfusion medicine

Back to National Blood Foundation

Last modified on 7/23/2009 11:24:37 AM
What's New!
AABB Weekly Report - March 12, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details